134 related articles for article (PubMed ID: 38789398)
1. A nanoemulsified formulation of dolutegravir and epigallocatechin gallate inhibits HIV-1 replication in cellular models.
Gaikwad SY; Tyagi S; Seniya C; More A; Chandane-Tak M; Kumar S; Mukherjee A
FEBS Lett; 2024 May; ():. PubMed ID: 38789398
[TBL] [Abstract][Full Text] [Related]
2. Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets.
Talib WH; Awajan D; Alqudah A; Alsawwaf R; Althunibat R; Abu AlRoos M; Al Safadi A; Abu Asab S; Hadi RW; Al Kury LT
Molecules; 2024 Mar; 29(6):. PubMed ID: 38543009
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of action of epigallocatechin gallate in cancer: Recent trends and advancement.
Aggarwal V; Tuli HS; Tania M; Srivastava S; Ritzer EE; Pandey A; Aggarwal D; Barwal TS; Jain A; Kaur G; Sak K; Varol M; Bishayee A
Semin Cancer Biol; 2022 May; 80():256-275. PubMed ID: 32461153
[TBL] [Abstract][Full Text] [Related]
4. Antitumor/anti-angiogenesis efficacy of epigallocatechin gallate nanoformulated with antioxidant in melanoma.
Sudha T; Salaheldin TA; Darwish NH; Mousa SA
Nanomedicine (Lond); 2022 Jun; 17(15):1039-1053. PubMed ID: 36102916
[No Abstract] [Full Text] [Related]
5. Epigallocatechin gallate/L-ascorbic acid-loaded poly-γ-glutamate microneedles with antioxidant, anti-inflammatory, and immunomodulatory effects for the treatment of atopic dermatitis.
Chiu YH; Wu YW; Hung JI; Chen MC
Acta Biomater; 2021 Aug; 130():223-233. PubMed ID: 34087444
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of green tea catechin, (-)-epigallocatechin-3-
Dinda B; Dinda S; Dinda M
Phytomed Plus; 2023 Feb; 3(1):100402. PubMed ID: 36597465
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin gallate inhibits the HIV reverse transcription step.
Li S; Hattori T; Kodama EN
Antivir Chem Chemother; 2011 Jul; 21(6):239-43. PubMed ID: 21730371
[TBL] [Abstract][Full Text] [Related]
8. In Vitro and In Silico Studies of the Molecular Interactions of Epigallocatechin-3-
Saeki K; Hayakawa S; Nakano S; Ito S; Oishi Y; Suzuki Y; Isemura M
Molecules; 2018 May; 23(6):. PubMed ID: 29843451
[TBL] [Abstract][Full Text] [Related]
9. (-)Epigallocatechin-3-gallate inhibits the spontaneous firing of rat locus coeruleus neuron.
Chang KC; Yang JJ; Wang-Hsu EC; Chiu TH; Hsu FC
Neurosci Lett; 2009 Mar; 452(2):141-5. PubMed ID: 19383428
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin Gallate Nanodelivery Systems for Cancer Therapy.
Granja A; Pinheiro M; Reis S
Nutrients; 2016 May; 8(5):. PubMed ID: 27213442
[TBL] [Abstract][Full Text] [Related]
11. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.
Wu D; Wang J; Pae M; Meydani SN
Mol Aspects Med; 2012 Feb; 33(1):107-18. PubMed ID: 22020144
[TBL] [Abstract][Full Text] [Related]
12. Targeted Pulmonary Delivery of the Green Tea Polyphenol Epigallocatechin Gallate Controls the Growth of
Sharma A; Vaghasiya K; Ray E; Gupta P; Gupta UD; Singh AK; Verma RK
ACS Biomater Sci Eng; 2020 Jul; 6(7):4126-4140. PubMed ID: 33463343
[TBL] [Abstract][Full Text] [Related]
13. Folate-targeted nanostructured lipid carriers for enhanced oral delivery of epigallocatechin-3-gallate.
Granja A; Vieira AC; Chaves LL; Nunes C; Neves AR; Pinheiro M; Reis S
Food Chem; 2017 Dec; 237():803-810. PubMed ID: 28764070
[TBL] [Abstract][Full Text] [Related]
14. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
Kazi J; Sen R; Ganguly S; Jha T; Ganguly S; Chatterjee Debnath M
Int J Pharm; 2020 Jul; 585():119449. PubMed ID: 32464231
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin gallate, the main polyphenol in green tea, binds to the T-cell receptor, CD4: Potential for HIV-1 therapy.
Williamson MP; McCormick TG; Nance CL; Shearer WT
J Allergy Clin Immunol; 2006 Dec; 118(6):1369-74. PubMed ID: 17157668
[TBL] [Abstract][Full Text] [Related]
16. Transdermal solid delivery of epigallocatechin-3-gallate using self-double-emulsifying drug delivery system as vehicle: Formulation, evaluation and vesicle-skin interaction.
Hu C; Gu C; Fang Q; Wang Q; Xia Q
J Biomater Appl; 2016 Feb; 30(7):1080-91. PubMed ID: 26637442
[TBL] [Abstract][Full Text] [Related]
17. The applications of epigallocatechin gallate (EGCG)-nanogold conjugate in cancer therapy.
Karimi-Shahri M; Alalikhan A; Hashemian P; Hashemzadeh A; Javid H
Nanotechnology; 2023 Mar; 34(21):. PubMed ID: 36535007
[TBL] [Abstract][Full Text] [Related]
18. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea as a candidate anti-HIV agent.
Fassina G; Buffa A; Benelli R; Varnier OE; Noonan DM; Albini A
AIDS; 2002 Apr; 16(6):939-41. PubMed ID: 11919502
[TBL] [Abstract][Full Text] [Related]
19. From tea to treatment; epigallocatechin gallate and its potential involvement in minimizing the metabolic changes in cancer.
Tauber AL; Schweiker SS; Levonis SM
Nutr Res; 2020 Feb; 74():23-36. PubMed ID: 31918176
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1).
Yamaguchi K; Honda M; Ikigai H; Hara Y; Shimamura T
Antiviral Res; 2002 Jan; 53(1):19-34. PubMed ID: 11684313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
